probes (denaturation at 75 °C for 3 minutes, hybridization at 37°C overnight). Following routine FISH washing (50% formamide/2xSSC twice for 5 minutes at 37°C, and 2X SSC for 5 minutes twice at 37°C), the centromere X probe was detected with streptavidin CY5 and slides were counterstained with DAPI. A minimum of 30 nuclei were scored in each assay. Only cells in which all three signals were clearly visible were counted. The Xist DNA probe effectively labelled Xist RNA on only one X chromosome in multiple normal female tissue preparations.
Sequencing
The complete WTX sequence was assembled from RACE-PCR and RT-PCR products derived from human and mouse neonatal kidneys. RT-PCR products from multiple sources were used to confirm the results. The assembled human WTX sequence differs from the annotated database sequence (Genbank AK097146) at the 3' end (Fig. S1 ).
Genomic DNA
The WTX gene was amplified from genomic DNA by PCR with primers listed in Table  S3 . Primers for WT1 are listed in Table S4 . Exon 3 of β-catenin was amplified and sequenced using 5' GCTGATTTGATGGAGTTGGACATGG 3' as a forward primer and 5' CTCTTACCAGCTACTTGTTCTTGAG 3' as a reverse primer. PCR products were purified and subjected to nucleotide sequencing using BigDye v1.1 (Applied Biosystems, Foster City CA). Tumor and reference sequences were aligned using sequence Navigator and Factura softwares (Applied Biosystems) and compared to identify homozygous and heterozygous nucleotide positions. All nucleotide variants were confirmed in at least two independent experiments. cDNA cDNA was prepared from 1 µg of total RNA using Superscript III and random hexamer primers according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). WTX was amplified with primers spanning one intron to prevent the amplification of genomic DNA and sequenced with appropriate internal primers. All sequences were confirmed in at least two independent reactions. The primers used were: Human WTX cDNA forward 5' ACAATAACCGGGCTAGGAACCTGAC 3' reverse 5' ATCATCATCTGGCAAGGCCATCT 3' internal 5' AAATGGCCTGTAAAGATCCAGAA 3'
Quantitative PCR (QPCR)
Quantitative PCR was performed using Power SYBR Green on an Applied Biosystems 7500 Real time PCR System (Applied Biosystems) using either genomic DNA or cDNA as a substrate. cDNA was synthesized from 1 µg of DNAse treated total RNA using Superscript III and random hexamer primers (Invitrogen 
Northern Blotting
Northern blotting was performed following standard protocols. Human fetal kidney RNA used for Northern blotting was purchased from Stratagene (La Jolla, CA). All other RNA samples were prepared as described above. Twenty micrograms of RNA was loaded per lane of 1.2% agarose formaldehyde gels and transferred to Hybond-N+ membranes (Amersham, Piscataway, New Jersey). Blots were subsequently probed with radioactive probes using ExpressHyb (Clontech, Mountain View, CA) and following the manufacturer's protocol. Radioactive probes were prepared by random primer labeling of cloned fragments of cDNA with radioactive dCTP (Perkin Elmer, Wellesley, MA) using the NEBlot Kit (New England Biolabs, Ipswich, MA) and following the manufacturer's instructions. The primers used to generate the Northern blot probes were as follows: 
RNA in situ hybridization
ISH was performed using standard protocols modified as described previously (5) . Frozen tissue sections were fixed in 4% paraformaldehyde, digested with proteinase K (4 μg/ml), treated with acetic anhydride and dehydrated with ethanol. Sections were hybridized overnight with sense and antisense digoxigenin labeled probes prepared with the DIG RNA Labeling Kit (Roche, Basel, Switzerland). Bound probes were detected using an alkaline phosphatase conjugated anti-digoxigenin antibody (Roche) and BM purple (Roche). The primers used to amplify probes were: Human WTX probe forward 5' CCAGGGCGGCTCAGCGGACAATAAC 3', reverse 5' CAGAACCTTTGCTCCGTCCCCCTCC 3' Human WT1 probe forward 5' AGCTCCAGCTCAGTGAAATGGACAGAAGGG 3', reverse 5' GTGATGGCGGACTAATTCATCTGACCGGGC 3'
Colony formation assays
The full WTX open reading frame was cloned by PCR into the pcDNA4TO expression vector (Invitrogen) with a 3' terminal FLAG tag. HEK-293 and U2OS cells were cultured in DMEM 10% FBS and plated in 12 well plates. Lipofectamine 2000 (Invitrogen) was used for cotransfection of empty vector or WTX expression vector and the selection plasmid pBABE puro. HEK-293 cells were transfected with 1 μg of expression vector and 0.1 μg of selection plasmid. 2 μg of expression vector and 0.5 μg of selection plasmid were used for U2OS cells. 50,000 HEK-293 cells and 20,000 U2OS cells were plated in 10-cm dishes after transfection. Following 2 weeks of selection in puromycin, colonies were counted automatically using Quantity One software (Biorad, Hercules, CA). All assays were performed in triplicate and repeated twice. 
Apoptosis assay

